1 / 29

Role of Targeted Radionuclide Therapy in the Current Treatment Paradigm for Men With CRPC

Role of Targeted Radionuclide Therapy in the Current Treatment Paradigm for Men With CRPC. Bone-Seeking Radiopharmaceuticals (BSRs) Current Role in the Management of Prostate Cancer. Radium-223 Dichloride Novel Alpha Particle–Emitting BSR.

wynter-haney
Télécharger la présentation

Role of Targeted Radionuclide Therapy in the Current Treatment Paradigm for Men With CRPC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Role of Targeted Radionuclide Therapy in the Current Treatment Paradigm for Men With CRPC

  2. Bone-Seeking Radiopharmaceuticals (BSRs)Current Role in the Management of Prostate Cancer

  3. Radium-223 DichlorideNovel Alpha Particle–Emitting BSR

  4. ALSYMPCA TrialA Phase 3 Study of Radium-223 Dichloride in Patients Who Have Symptomatic CRPC With Skeletal Metastases

  5. Other Bone-Targeting TherapiesWill the role for zoledronic acid and denosumab change?

  6. Radium-223Where does it fit in current practice?

  7. Spectrum of Metastatic CRPCHow much visceral disease could a patient have to still be considered a candidate for treatment with radium-223?

  8. Radium-223Integrating It With Novel Hormonal Therapies

  9. Radium-223Potential Barriers to Its Use and How to Overcome Them

More Related